The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis

被引:0
作者
Rezaeimanesh, Nasim [1 ,2 ,3 ]
Abbasi, Naghmeh [3 ]
Sahraian, Mohammad Ali [3 ]
Azimi, Amirreza [3 ]
Razeghi-Jahromi, Soodeh [1 ,2 ,3 ]
Moghadasi, Abdorreza Naser [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Nutr Sci & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Tehran, Iran
[3] Univ Tehran Med Sci, Neurosci Inst, Multiple Sclerosis Res Ctr Tehran, Tehran, Iran
来源
CURRENT JOURNAL OF NEUROLOGY | 2023年 / 22卷 / 01期
关键词
Body Mass Index; COVID-19; Multiple Sclerosis; Obesity; Symptom Assessment; Risk; VIRUS-INFECTION; OBESITY;
D O I
10.18502/cjn.v22i1.12613
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It seems that patients with multiple sclerosis (MS) are at a higher risk for coronavirus disease 2019 (COVID-19) implications due to being subjected to immunomodulatory or immunosuppressive treatments. Besides, obesity as a risk factor may lead to more adverse consequences. The relationship between obesity and COVID-19 morbidity and outcomes in Iranian patients with MS still remains unclear.Methods: A cross-sectional study was conducted in Sina Hospital, Tehran, Iran. Patients with MS were asked to complete an online questionnaire in the Google Form format. Demographic information, clinical information including MS disease-related factors, COVID-19-related factors, and anthropometric information were recorded. Totally, 492 patients filled the questionnaire during two weeks in November 2021, by the response rate of 21.6%. Body mass index (BMI) was categorized based on the standard classification of the World Health Organization (WHO). The logistic regression was used to examine the risk of morbidity and chi-square test/one-way analysis of variance (ANOVA) was employed to determine the difference regarding severity and symptoms among groups.Results: In the fully adjusted model, the odds ratio (OR) of COVID-19 morbidity in class II obese participants was significantly 5.41 times higher than that in the normal BMI group [OR: 5.41, 95% confidence interval (CI): 1.00-29.09]. COVID-19 severity was significantly different among BMI groups (P = 0.024). Respiratory symptoms (P = 0.05) as well as gastrointestinal (GI) symptoms (P < 0.01) of COVID-19 were more prevalent among class I and class II obese patients compared with overweight, normal weight, and underweight groups. Moreover, no one in the class I and class II obesity groups reported COVID-19 morbidity without any symptoms (P = 0.04).Conclusion: The results of the current study support the view that obesity could play a key role in susceptibility to COVID-19 morbidity and severity of the symptoms in patients with MS. The findings recommended that neurologists pay more attention to patients' BMI during this pandemic.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 23 条
[1]   The potential impacts of obesity on COVID-19 [J].
Albashir, Ahmed Abdalazim Dafallah .
CLINICAL MEDICINE, 2020, 20 (04) :E109-E113
[2]   Impact of Obesity and Metabolic Syndrome on Immunity [J].
Andersen, Catherine J. ;
Murphy, Kelsey E. ;
Fernandez, Maria Luz .
ADVANCES IN NUTRITION, 2016, 7 (01) :66-75
[3]   The Coronavirus Disease 2019 (COVID-19) Pandemic [J].
Baloch, Saira ;
Baloch, Mohsin Ali ;
Zheng, Tianli ;
Pei, Xiaofang .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 250 (04) :271-278
[4]  
Centers for Disease Control and Prevention, Underlying medical conditions associated with higher risk for severe COVID-19: information for healthcare professionals
[5]  
Centers for Disease Control and Prevention, 2020, SYMPT COVID 19
[6]   Clinical manifestations of COVID-19 differ by age and obesity status [J].
Cheng, Wesley A. ;
Turner, Lauren ;
Marentes Ruiz, Carolyn J. ;
Tanaka, Melissa L. ;
Congrave-Wilson, Zion ;
Lee, Yesun ;
Jumarang, Jaycee ;
Perez, Stephanie ;
Peralta, Ariana ;
Pannaraj, Pia S. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (02) :255-264
[7]   Gastrointestinal symptoms and obesity: a meta-analysis [J].
Eslick, G. D. .
OBESITY REVIEWS, 2012, 13 (05) :469-479
[8]   Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) [J].
Holt, Hayley ;
Talaei, Mohammad ;
Greenig, Matthew ;
Zenner, Dominik ;
Symons, Jane ;
Relton, Clare ;
Young, Katherine S. ;
Davies, Molly R. ;
Thompson, Katherine N. ;
Ashman, Jed ;
Rajpoot, Sultan Saeed ;
Kayyale, Ahmed Ali ;
El Rifai, Sarah ;
Lloyd, Philippa J. ;
Jolliffe, David ;
Timmis, Olivia ;
Finer, Sarah ;
Iliodromiti, Stamatina ;
Miners, Alec ;
Hopkinson, Nicholas S. ;
Alam, Bodrul ;
Lloyd-Jones, Graham ;
Dietrich, Thomas ;
Chapple, Iain ;
Pfeffer, Paul E. ;
McCoy, David ;
Davies, Gwyneth ;
Lyons, Ronan A. ;
Griffiths, Christopher ;
Kee, Frank ;
Sheikh, Aziz ;
Breen, Gerome ;
Shaheen, Seif O. ;
Martineau, Adrian R. .
THORAX, 2022, 77 (09) :900-912
[9]   Diet-Induced Obesity in Mice Reduces the Maintenance of Influenza-Specific CD8+Memory T Cells [J].
Karlsson, Erik A. ;
Sheridan, Patricia A. ;
Beck, Melinda A. .
JOURNAL OF NUTRITION, 2010, 140 (09) :1691-1697
[10]   Risk of COVID-19 for patients with obesity [J].
Kassir, Radwan .
OBESITY REVIEWS, 2020, 21 (06)